Advertisement Disease Models, In Vivo PK, and Safety Pharmacology and Toxicology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
close icon

SBW

Drug Candidate Validation Services

More info about SBW

Disease Models, In Vivo PK, and Safety Pharmacology and Toxicology

SBW

Disease models

  • Cardiovascular and metabolic diseases, diabetes, oncology, dermatology, gastrointestinal diseases and CNS models (e.g. Alzheimer’s and Parkinson’s, stroke and epilepsy)

In vivo PK

  • Available species are rat, mouse, dog, rabbit and guinea pig
  • Formulation for dosing (vehicle finding and vehicle stability)

Safety pharmacology and toxicology

  • Modified Irwin test in mice and rats
  • Locomotor activity
  • Anti and pro-convulsant activity
  • Analgesic activity
  • Motor coordination
  • BP and HR with telemetry
  • Pulmonary functions and whole body plethysmography

In vivo disease models

We have more than 30 in vivo disease models, including:

  • Tail-transection bleeding time test
  • Renal / urinary system
  • Gastrointestinal safety
  • Toxicity screening and maximum tolerated dose
  • GLP in vitro toxicology assays
  • GLP in vivo toxicology assays, including respiratory toxicity
Quick Contact Disease Models, In Vivo PK, and Safety Pharmacology and Toxicology